Insulin-like growth factors in the gastrointestinal tract and liver
- PMID: 22682638
- PMCID: PMC3372868
- DOI: 10.1016/j.ecl.2012.04.018
Insulin-like growth factors in the gastrointestinal tract and liver
Abstract
The liver is a major source of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) that are present in the circulation and have important endocrine activities relating to energy metabolism, body size, carcinogenesis, and various organ-specific functions. Although IGFs have only minor effects on the normal liver itself, production of IGFs and IGFBPs in a tissue-specific manner in the gastrointestinal tract exert important regulatory effects on cellular proliferation, survival, and apoptosis. IGFs and IGFBPs play important regulatory roles in the response of both the liver and the gastrointestinal tract to inflammation and in the development of neoplasia.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
References
-
- LeRoith D. Insulin-like growth factor receptors and binding proteins. Baillieres Clin Endocrinol Metab. 1996;10:49–73. - PubMed
-
- Rubin R, Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, tumorigenicity. Lab Invest. 1995;73:311–331. - PubMed
-
- Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3–34. - PubMed
-
- Nielsen FC. The molecular and cellular biology of insulin-like growth factor II. Prog Growth Factor Res. 1992;4:257–290. - PubMed
-
- Sussenbach JS. The gene structure of the insulin-like growth factor family. Prog Growth Factor Res. 1989;1:33–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
